<p>長期投資效果良好，但並不總是適用於每隻個股。我們不希望任何人遭受災難性的資本損失。想象一下，如果你持有 <strong>海吉亞醫療控股有限公司</strong>（HKG:6078）長達五年，而股價暴跌了 71%。而且不僅僅是長期持有者受到傷害，因為該股票在過去一年中下跌了 41%。不過在過去一週內上漲了 5.6%。這可能與強勁的市場有關，因為同期股票整體上漲了約 2.9%。</p>
<p>儘管該股票在過去一週上漲了 5.6%，但長期股東仍處於虧損狀態，讓我們看看基本面能告訴我們什麼。</p>
<p>這項技術可能會取代計算機：發現 20 只正在努力使量子計算成為現實的股票。</p>
<p>用本傑明·格雷厄姆的話説：在短期內，市場是一個投票機，但在長期內，它是一個稱重機。檢查市場情緒如何隨時間變化的一種方法是觀察公司股價與每股收益（EPS）之間的互動。</p>
<p>儘管股價在五年內下跌，海吉亞醫療控股實際上每年平均成功將 EPS_提高_了 48%。考慮到股價反應，人們可能會懷疑 EPS 在此期間是否是評估業務表現的良好指標（可能是由於一次性損失或收益）。或者，過去的增長預期可能是不合理的。</p>
<p>由於 EPS 增長率與股價增長之間的明顯對比，我們傾向於尋找其他指標來理解市場情緒如何變化。</p>
<p>與股價相反，五年期間的收入實際上每年增長了 24%。對收入和收益的更詳細檢查可能會解釋股價低迷的原因；這可能是一個機會。</p>
<p>你可以在下面的圖像中看到收益和收入隨時間的變化（點擊圖表查看確切數值）。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/668694163-earnings-and-revenue-growth-1-dark-2/1759710194522?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/668694163-earnings-and-revenue-growth-1-dark-2/1759710194522"/></p>
<p>SEHK:6078 收益和收入增長 2025 年 10 月 6 日</p>
<p>看到在過去三個月內有一些顯著的內部人士買入是件好事。這是一個積極的信號。另一方面，我們認為收入和收益的趨勢是衡量業務更有意義的指標。你可以在這個 <strong>互動</strong> 圖表中看到分析師對海吉亞醫療控股未來利潤預測的看法。</p>
<h2>不同的視角</h2>
<p>海吉亞醫療控股的投資者經歷了艱難的一年，總損失為 41%，而市場則上漲了約 26%。即使是優秀股票的股價有時也會下跌，但在我們對業務產生濃厚興趣之前，我們希望看到基本指標的改善。不幸的是，去年的表現可能表明存在未解決的挑戰，因為其表現比過去五年年化損失 11% 還要糟糕。我們意識到巴倫·羅斯柴爾德曾説過，投資者應該在 “街上有血時” 買入，但我們提醒投資者首先要確保他們購買的是高質量的企業。如果你想進一步研究這隻股票，內部人士買入的數據顯然是一個好的起點。你可以點擊這裏查看誰在購買股票——以及他們支付的價格。</p>
<p>還有很多其他公司也有內部人士在買入股票。你可能不想錯過這份 <strong>免費</strong> 的被低估的小型公司的名單，這些公司內部人士正在買入。</p>
<p><em>請注意，本文中引用的市場回報反映了目前在香港交易所交易的股票的市場加權平均回報。</em></p>

海吉亞醫療

<p>海吉亞醫療控股（HKG:6078）的股價出現了顯著下跌，過去五年下跌了 71%，去年下跌了 41%。儘管每股收益（EPS）年增長 48%，收入年增長 24%，但近期內部人士的買入是一個積極信號。然而，建議投資者在做出決策之前關注基本面指標。該股票相較於市場收益的表現不佳，引發了對潛在挑戰的擔憂，建議潛在投資者採取謹慎的態度</p>

<p>Long term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic capital loss on anyone. Imagine if you held <strong>Hygeia Healthcare Holdings Co., Limited</strong> (HKG:6078) for half a decade as the share price tanked 71%. And it's not just long term holders hurting, because the stock is down 41% in the last year. But it's up 5.6% in the last week. But this could be related to the strong market, with stocks up around 2.9% in the same time.</p>
<div class="lb-trans"><p>長期投資效果良好，但並不總是適用於每隻個股。我們不希望任何人遭受災難性的資本損失。想象一下，如果你持有 <strong>海吉亞醫療控股有限公司</strong>（HKG:6078）長達五年，而股價暴跌了 71%。而且不僅僅是長期持有者受到傷害，因為該股票在過去一年中下跌了 41%。不過在過去一週內上漲了 5.6%。這可能與強勁的市場有關，因為同期股票整體上漲了約 2.9%。</p>
</div><p>While the stock has risen 5.6% in the past week but long term shareholders are still in the red, let's see what the fundamentals can tell us.</p>
<div class="lb-trans"><p>儘管該股票在過去一週上漲了 5.6%，但長期股東仍處於虧損狀態，讓我們看看基本面能告訴我們什麼。</p>
</div><p>This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.</p>
<div class="lb-trans"><p>這項技術可能會取代計算機：發現 20 只正在努力使量子計算成為現實的股票。</p>
</div><p>To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).</p>
<div class="lb-trans"><p>用本傑明·格雷厄姆的話説：在短期內，市場是一個投票機，但在長期內，它是一個稱重機。檢查市場情緒如何隨時間變化的一種方法是觀察公司股價與每股收益（EPS）之間的互動。</p>
</div><p>While the share price declined over five years, Hygeia Healthcare Holdings actually managed to <em>increase</em> EPS by an average of 48% per year. Given the share price reaction, one might suspect that EPS is not a good guide to the business performance during the period (perhaps due to a one-off loss or gain). Alternatively, growth expectations may have been unreasonable in the past.</p>
<div class="lb-trans"><p>儘管股價在五年內下跌，海吉亞醫療控股實際上每年平均成功將 EPS_提高_了 48%。考慮到股價反應，人們可能會懷疑 EPS 在此期間是否是評估業務表現的良好指標（可能是由於一次性損失或收益）。或者，過去的增長預期可能是不合理的。</p>
</div><p>Because of the sharp contrast between the EPS growth rate and the share price growth, we're inclined to look to other metrics to understand the changing market sentiment around the stock.</p>
<div class="lb-trans"><p>由於 EPS 增長率與股價增長之間的明顯對比，我們傾向於尋找其他指標來理解市場情緒如何變化。</p>
</div><p>In contrast to the share price, revenue has actually increased by 24% a year in the five year period. A more detailed examination of the revenue and earnings may or may not explain why the share price languishes; there could be an opportunity.</p>
<div class="lb-trans"><p>與股價相反，五年期間的收入實際上每年增長了 24%。對收入和收益的更詳細檢查可能會解釋股價低迷的原因；這可能是一個機會。</p>
</div><p>You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).</p>
<div class="lb-trans"><p>你可以在下面的圖像中看到收益和收入隨時間的變化（點擊圖表查看確切數值）。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/668694163-earnings-and-revenue-growth-1-dark-2/1759710194522" alt="" original-src="https://images.simplywall.st/asset/chart/668694163-earnings-and-revenue-growth-1-dark-2/1759710194522"/></p>
<p>SEHK:6078 Earnings and Revenue Growth October 6th 2025</p>
<div class="lb-trans"><p>SEHK:6078 收益和收入增長 2025 年 10 月 6 日</p>
</div><p>It's good to see that there was some significant insider buying in the last three months. That's a positive. On the other hand, we think the revenue and earnings trends are much more meaningful measures of the business. You can see what analysts are predicting for Hygeia Healthcare Holdings in this <strong>interactive</strong> graph of future profit estimates.</p>
<div class="lb-trans"><p>看到在過去三個月內有一些顯著的內部人士買入是件好事。這是一個積極的信號。另一方面，我們認為收入和收益的趨勢是衡量業務更有意義的指標。你可以在這個 <strong>互動</strong> 圖表中看到分析師對海吉亞醫療控股未來利潤預測的看法。</p>
</div><h2>A Different Perspective</h2>
<div class="lb-trans"><h2>不同的視角</h2>
</div><p>Investors in Hygeia Healthcare Holdings had a tough year, with a total loss of 41%, against a market gain of about 26%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 11% over the last half decade. We realise that Baron Rothschild has said investors should &#34;buy when there is blood on the streets&#34;, but we caution that investors should first be sure they are buying a high quality business. If you want to research this stock further, the data on insider buying is an obvious place to start. You can click here to see who has been buying shares - and the price they paid.</p>
<div class="lb-trans"><p>海吉亞醫療控股的投資者經歷了艱難的一年，總損失為 41%，而市場則上漲了約 26%。即使是優秀股票的股價有時也會下跌，但在我們對業務產生濃厚興趣之前，我們希望看到基本指標的改善。不幸的是，去年的表現可能表明存在未解決的挑戰，因為其表現比過去五年年化損失 11% 還要糟糕。我們意識到巴倫·羅斯柴爾德曾説過，投資者應該在 “街上有血時” 買入，但我們提醒投資者首先要確保他們購買的是高質量的企業。如果你想進一步研究這隻股票，內部人士買入的數據顯然是一個好的起點。你可以點擊這裏查看誰在購買股票——以及他們支付的價格。</p>
</div><p>There are plenty of other companies that have insiders buying up shares. You probably do <strong>not</strong> want to miss this <strong>free</strong> list of undervalued small cap companies that insiders are buying.</p>
<div class="lb-trans"><p>還有很多其他公司也有內部人士在買入股票。你可能不想錯過這份 <strong>免費</strong> 的被低估的小型公司的名單，這些公司內部人士正在買入。</p>
</div><p><em>Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Hong Kong exchanges.</em></p>
<div class="lb-trans"><p><em>請注意，本文中引用的市場回報反映了目前在香港交易所交易的股票的市場加權平均回報。</em></p>
</div>

儘管收益增長為正，但在過去五年中，海吉亞醫療控股（HKG:6078）的股東仍未能獲得理想的回報